More tumor mutations equals higher success rate with cancer immunotherapy drugs – EurekAlert (press release)
EurekAlert (press release) |
More tumor mutations equals higher success rate with cancer immunotherapy drugs
EurekAlert (press release) Work by Dung Le, M.D., associate professor of oncology, and other researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Cancer Institute for Cancer Immunotherapy showed that colon cancers that carry a high number of mutations … |
